Clinical outcome of inpatient treatment of osteoporotic sacral and pelvic ring fractures

Bernhard Ullrich, Ulrich Spiegl(University Hospital Leipzig), Georg Osterhoff(Unfallkrankenhaus Berlin), Philipp Hartung(St. Josefs Hospital), Felix C. Kohler(St. Josefs Hospital), Robert Paetzold(Berufsgenossenschaftliche Unfallklinik Murnau), L. Behr(Inserm), Klaus John Schnake(Schön Klinik Nürnberg Fürth), S. Grüninger(Paracelsus Medizinische Privatuniversität), Philipp Schenk(BG Klinikum Bergmannstrost Halle), Frank Hartmann(Universität Hamburg), S. Klunk(Ostfalia University of Applied Sciences), P. Schanderl(University Hospital Leipzig), Mathias Müller(University of Veterinary Medicine Vienna), E. Wegener(Johannes Gutenberg University Mainz), Max J. Scheyerer(University of Cologne)
Brain and Spine
January 1, 2024
10.1016/j.bas.2024.104108
Cited by 0

Related Papers

Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (GLSG)
|Blood|2006|465
Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon‐alpha and ‐gamma signal transduction pathways.
|The EMBO Journal|1993|415
Stromal Antigen Targeting by a Humanised Monoclonal Antibody: An Early Phase II Trial of Sibrotuzumab in Patients with Metastatic Colorectal Cancer
|Oncology Research and Treatment|2003|364
Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock
|Nature Immunology|2003|363
Comparison of newer generation self-expandable vs. balloon-expandable valves in transcatheter aortic valve implantation: the randomized SOLVE-TAVI trial
|European Heart Journal|2020|263